Benjamin Vigl

853 total citations
10 papers, 742 citations indexed

About

Benjamin Vigl is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Benjamin Vigl has authored 10 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Benjamin Vigl's work include Lymphatic System and Diseases (6 papers), Lymphatic Disorders and Treatments (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Benjamin Vigl is often cited by papers focused on Lymphatic System and Diseases (6 papers), Lymphatic Disorders and Treatments (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Benjamin Vigl collaborates with scholars based in Switzerland, Austria and United States. Benjamin Vigl's co-authors include Cornelia Halin, Michael Detmar, Maximilian Nitschké, David Aebischer, Lawrence F. Brown, Maria Iolyeva, Olga Antsiferova, Oskar W. Smrzka, Eliezer Masliah and Christina Patrick and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Benjamin Vigl

9 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Vigl Switzerland 9 397 206 172 168 161 10 742
Yohei Kawai Japan 14 282 0.7× 304 1.5× 177 1.0× 78 0.5× 216 1.3× 42 815
Yaël Gothelf Israel 16 85 0.2× 291 1.4× 167 1.0× 70 0.4× 258 1.6× 27 798
Takaaki Ishizu Japan 15 146 0.4× 277 1.3× 311 1.8× 78 0.5× 556 3.5× 22 1.2k
Shigeaki Hori Japan 19 146 0.4× 193 0.9× 52 0.3× 48 0.3× 290 1.8× 41 875
Cheryl D’Souza Canada 13 147 0.4× 251 1.2× 219 1.3× 69 0.4× 183 1.1× 15 687
Heiner Adams Switzerland 13 133 0.3× 262 1.3× 39 0.2× 75 0.4× 273 1.7× 20 802
Makoto Araie Japan 24 128 0.3× 286 1.4× 42 0.2× 76 0.5× 78 0.5× 57 1.5k
Shuhong Liu China 9 132 0.3× 120 0.6× 85 0.5× 59 0.4× 29 0.2× 17 568
Yuka Ikegame Japan 12 134 0.3× 245 1.2× 50 0.3× 82 0.5× 89 0.6× 31 741
Lauren M. Goddard United States 8 80 0.2× 396 1.9× 86 0.5× 180 1.1× 204 1.3× 9 868

Countries citing papers authored by Benjamin Vigl

Since Specialization
Citations

This map shows the geographic impact of Benjamin Vigl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Vigl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Vigl more than expected).

Fields of papers citing papers by Benjamin Vigl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Vigl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Vigl. The network helps show where Benjamin Vigl may publish in the future.

Co-authorship network of co-authors of Benjamin Vigl

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Vigl. A scholar is included among the top collaborators of Benjamin Vigl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Vigl. Benjamin Vigl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tretter, Verena, Benjamin Vigl, Marko Poglitsch, et al.. (2023). Combined angiotensin-converting enzyme and aminopeptidase inhibition for treatment of experimental ventilator-induced lung injury in mice. Frontiers in Physiology. 14. 1109452–1109452.
2.
Vigl, Benjamin, et al.. (2017). Quantitative in vitro and in vivo models to assess human IgE B cell receptor crosslinking by IgE and EMPD IgE targeting antibodies. Journal of Immunological Methods. 449. 28–36. 8 indexed citations
3.
Mandler, Markus, Elvira Valera, Edward Rockenstein, et al.. (2014). Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials. Acta Neuropathologica. 127(6). 861–879. 188 indexed citations
4.
Nitschké, Maximilian, David Aebischer, Michael Abadier, et al.. (2012). Differential requirement for ROCK in dendritic cell migration within lymphatic capillaries in steady-state and inflammation. Blood. 120(11). 2249–2258. 85 indexed citations
5.
Iolyeva, Maria, Sinem Karaman, Ann‐Helen Willrodt, et al.. (2012). Novel role for ALCAM in lymphatic network formation and function. The FASEB Journal. 27(3). 978–990. 38 indexed citations
6.
Vigl, Benjamin, David Aebischer, Maximilian Nitschké, et al.. (2011). Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner. Blood. 118(1). 205–215. 164 indexed citations
7.
Mumprecht, Viviane, Michael Honer, Benjamin Vigl, et al.. (2010). In vivo Imaging of Inflammation- and Tumor-Induced Lymph Node Lymphangiogenesis by Immuno–Positron Emission Tomography. Cancer Research. 70(21). 8842–8851. 70 indexed citations
8.
Boucheron, Nicole, Omar Sharif, Alexandra Schebesta, et al.. (2010). The Protein Tyrosine Kinase Tec Regulates a CD44highCD62L− Th17 Subset. The Journal of Immunology. 185(9). 5111–5119. 13 indexed citations
9.
Vigl, Benjamin, et al.. (2008). Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitro. Experimental Cell Research. 315(2). 336–347. 26 indexed citations
10.
Halin, Cornelia, et al.. (2007). VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood. 110(9). 3158–3167. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026